Pandox AB (FRA:POX) Cash Flow from Financing: €1,007.7 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:POX Pandox AB FRA:POX
73 GF Score
Price €15.72
GF Value €17.30
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Pandox AB Cash Flow from Financing?

Pandox AB FRA:POX -0.38% 73 Cash Flow from Financing is €1,007.7 Mil as of Jun. 2026. GuruFocus rates FRA:POX with a GF Score™ of 73/100 and a GF Value™ of €17.30 (Fairly Valued). The stock has 7 warning signs investors should review.

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Jun. 2026, Pandox AB paid €0.0 Mil more to buy back shares than it received from issuing new shares. It received €28.2 Mil from issuing more debt. It paid €0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent €79.9 Mil paying cash dividends to shareholders. It spent €0.0 Mil on other financial activities. In all, Pandox AB spent €51.7 Mil on financial activities for the three months ended in Jun. 2026.


Pandox AB  (FRA:POX) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Pandox AB's issuance of stock for the three months ended in Jun. 2026 was €0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Pandox AB's repurchase of stock for the three months ended in Jun. 2026 was €0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Pandox AB's net issuance of debt for the three months ended in Jun. 2026 was €28.2 Mil. Pandox AB received €28.2 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Pandox AB's net issuance of preferred for the three months ended in Jun. 2026 was €0.0 Mil. Pandox AB paid €0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Pandox AB's cash flow for dividends for the three months ended in Jun. 2026 was €-79.9 Mil. Pandox AB spent €79.9 Mil paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Pandox AB's other financing for the three months ended in Jun. 2026 was €-0.0 Mil. Pandox AB spent €0.0 Mil on other financial activities.


Pandox AB Cash Flow from Financing Related Terms


Pandox AB Cash Flow from Financing Historical Data

* Premium members only.

The historical data trend for Pandox AB's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pandox AB Cash Flow from Financing Chart

Pandox AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.06 -73.32 -152.07 234.47 1,264.16

Pandox AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 105.60 346.16 705.27 7.98 -51.72
FRA:POX
73GF Score
Pandox AB FRA:POX
Cash Flow from Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pandox AB Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Pandox AB's Cash from Financing for the fiscal year that ended in Dec. 2025 is calculated as:

Pandox AB's Cash from Financing for the quarter that ended in Jun. 2026 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,007.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Financing of €1,007.7 Mil mean?
Pandox AB (FRA:POX) has a Cash Flow from Financing of €1,007.7 Mil as of Jun. 2026. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Pandox AB and its competitors.
Is Pandox AB's Cash Flow from Financing too high?
Pandox AB's current Cash Flow from Financing is €1,007.7 Mil. Overall, Pandox AB has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pandox AB's Cash Flow from Financing compare to CBRE and BEKE?
Pandox AB's Cash Flow from Financing of €1,007.7 Mil can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Real Estate company?
A good Cash Flow from Financing depends on the Real Estate industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Pandox AB and its competitors. Pandox AB's current Cash Flow from Financing is €1,007.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pandox AB stock overvalued right now?
Based on GuruFocus' analysis, Pandox AB (FRA:POX) is currently considered Fairly Valued. The stock's GF Value™ is €17.30, compared to a current price of €15.72 — trading 9.1% below its estimated fair value. The current Cash Flow from Financing is €1,007.7 Mil. Pandox AB's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Pandox AB (FRA:POX), the current Cash Flow from Financing is €1,007.7 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pandox AB (FRA:POX) Overvalued in 2026?

Based on GuruFocus' analysis, Pandox AB stock appears to be undervalued. The current stock price of €15.72 is trading 9.1% below its estimated GF Value™ of €17.30. GuruFocus considers Pandox AB to be Fairly Valued.

Key valuation signals for FRA:POX:

  • Cash Flow from Financing: €1,007.7 Mil
  • GF Value™: €17.30 vs. price of €15.72 (9.1% below fair value)
  • GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the FRA:POX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pandox AB Business Description

Other Exchanges PNDX B:Sweden0R8U:UK
Address Vasagatan 11, 9th floor, Box 15, Stockholm, SWE, SE-101 20
Pandox AB is a hotel property company focused on owning, developing, and leasing hotel properties to hotel operators, with its business concept based on long-term, revenue-based leases with guaranteed minimum levels. It also operates certain hotels itself as part of its ownership. Its activities include property management, property development, and portfolio optimisation, along with leasing hotel properties and operating hotels under its Own Operations segment. The Company operates through two main segments, namely Leases, which contributes the maximum revenue and is the core business with long-term revenue-based lease agreements, and Own Operations, where the Company operates hotels in its own properties. Geographically, Pandox has a presence across Europe.
73GF Score

Get the complete analysis for FRA:POX

Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.72
Price
€17.30
GF Value